However, we make several potential links to variation within AD patients on both the nonlesional and lesional skin, including AD severity and filaggrin mutations, while the lesional skin location on the body was further linked to variation in the lesional bacterial communities. The gene discussed is FLG; the disease is Alzheimer disease.